Icon

TAPAZOLE (nda007517)- (5MG,10MG)

METHIMAZOLE KING PHARMS
5MG,10MG
No No
Expired Expired
None None
None No
TAPAZOLE is indicated:  In patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option.  To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.
8 0 7
Total Other Developers None
Drugs with Suitability Yes
5MG ** ** - - 7
10MG ** ** - - 7
NDA Sales Available Total Generic Sales Available
No 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ******* ******, *** *********** * *** ***** **, ******** *****, *** **** (**) *****-****, ****** ****** (***) ***
****** ********* ** ********* *************** *******, ***. *********** ** ******* *****, *** ***** ******, *******, *** **** (**) *****, ****** ****** (***) ***
****** ******* ****** ***** *&* **************, ***. *********** *** **** ****** ***** ***, *********, *** **** (**) *****, ****** ****** (***) ***
****** ******** ****** ******** ****** **** ***. */*/* **** *************** **** ***. *********** *** ******* **, **** *********, *** ****** (**) *****, ****** ****** (***) ***
****** ******** ****** *** ******** *************** ******* *********** ******* *****, **** ****** **********,****** *****, ******** *****, ******** ******* ******, ***** (***) ***
****** ******** ****** *** ****** **** *********** ******* *****, *.*. **********, ****** - *****, *****, ******** ******* ******, ***** (***) ***
****** ********** ****** *************** ******* ******* *********** **** **.** (****) *** ** (****), ****** ********** ****, ***************, *************, ************, ***** **** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.